NYSE:CLB

Core Laboratories (CLB) Stock Price, News & Analysis

Core Laboratories logo
$7.74 -0.66 (-7.80%)
Closing price 03:59 PM Eastern
Extended Trading
$7.76 +0.01 (+0.13%)
As of 04:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Core Laboratories Stock (NYSE:CLB)

Advanced

Key Stats

Today's Range
$7.71
▼
$8.37
50-Day Range
$8.37
▼
$12.50
52-Week Range
$7.71
▼
$20.36
Volume
847,402 shs
Average Volume
597,614 shs
Market Capitalization
$354.88 million
P/E Ratio
20.38
Dividend Yield
0.52%
Price Target
$21.00
Consensus Rating
Hold

Company Overview

Core Laboratories Inc. provides specialized services and products to the oil and natural gas industry. Its work helps customers evaluate reservoirs and improve the performance of producing wells.

The company’s Reservoir Description business analyzes rock and fluid samples and provides laboratory testing, data, and reservoir studies. These services help energy companies assess subsurface properties and make decisions about exploration and field development.

Through its Production Enhancement business, Core Laboratories offers well diagnostics, completion-related services, and technologies designed to support production and improve recovery. The company serves energy customers internationally, with operations across major oil and gas regions.

AI Generated. May Contain Errors.

Core Laboratories Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
62nd Percentile Overall Score

CLB MarketRank™: 
3.119266055045 of 5 stars

Core Laboratories scored higher than 62% of companies evaluated by MarketBeat, and ranked 157th out of 239 stocks in the energy sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Core Laboratories has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.

  • Upside Potential

    Core Laboratories has a consensus price target of $21.00, representing about 164.5% upside from its current price of $7.94.

  • Amount of Analyst Coverage

    Core Laboratories has only been the subject of 1 research reports in the past 90 days.

  • Read more about Core Laboratories' stock forecast and price target.
  • Earnings Growth

    Earnings for Core Laboratories are expected to grow by 41.07% in the coming year, from $0.56 to $0.79 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Core Laboratories is 20.92, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.42.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Core Laboratories is 20.92, which means that it is trading at a more expensive P/E ratio than the Energy sector average P/E ratio of about 20.90.

  • Price to Earnings Growth Ratio

    Core Laboratories has a PEG Ratio of 1.70. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Core Laboratories has a P/B Ratio of 1.28. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Core Laboratories' valuation and earnings.
  • Percentage of Shares Shorted

    10.95% of the float of Core Laboratories has been sold short.
  • Short Interest Ratio / Days to Cover

    Core Laboratories has a short interest ratio ("days to cover") of 6.76.
  • Change versus previous month

    Short interest in Core Laboratories has recently increased by 0.76%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Core Laboratories has a dividend yield of 0.47%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Core Laboratories does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Core Laboratories is 10.53%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Core Laboratories will have a dividend payout ratio of 5.06% next year. This indicates that Core Laboratories will be able to sustain or increase its dividend.

  • Read more about Core Laboratories' dividend.
  • News Sentiment

    Core Laboratories has a news sentiment score of 0.32. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Energy companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for Core Laboratories this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Core Laboratories insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    1.26% of the stock of Core Laboratories is held by insiders.

  • Percentage Held by Institutions

    97.81% of the stock of Core Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Core Laboratories' insider trading history.
Receive CLB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Core Laboratories and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CLB Stock News Headlines

Core Laboratories (CLB) Q3 2026 Earnings Call Transcript
This is likely to EXPLODE
Dr. Martin D. Weiss, founder of Weiss Ratings and a two-time Congressional witness on financial institution risk, is warning of a looming $3 trillion threat in today's financial system. He says the same ratings agency practices that preceded the 2008 crisis are repeating themselves, while regulators stay quiet about the risks.tc pixel
See More Headlines

CLB Stock Analysis - Frequently Asked Questions

Core Laboratories' stock was trading at $16.02 at the beginning of 2026. Since then, CLB stock has decreased by 50.4% and is now trading at $7.9390.

Core Laboratories Inc. (NYSE:CLB) released its quarterly earnings data on Wednesday, October, 28th. The oil and gas company reported $0.16 EPS for the quarter, topping analysts' consensus estimates of $0.16 by $0.00. Core Laboratories's quarterly revenue was down 1.8% compared to the same quarter last year.
Read the conference call transcript
.

Core Laboratories' top institutional shareholders include State Street Corp (3.40%), Heartland Advisors Inc. (2.44%), Goldman Sachs Group Inc. (1.63%) and Archon Capital Management LLC (0.98%).
View institutional ownership trends
.

Shares of CLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Core Laboratories investors own include Netflix (NFLX), Boeing (BA), Gilead Sciences (GILD), Micron Technology (MU), Starbucks (SBUX), Mastercard (MA) and Intel (INTC).

Company Calendar

Record date for 8/31 Dividend
8/10/2026
Ex-Dividend for 8/31 Dividend
8/10/2026
Dividend Payable
8/31/2026
Last Earnings
10/28/2026
Record date for 11/30 Dividend
11/09/2026
Ex-Dividend for 11/30 Dividend
11/09/2026
Today
11/20/2026
Dividend Payable
11/30/2026
Fiscal Year End
12/31/2026
Next Earnings (Estimated)
2/03/2027

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Energy
Industry
Energy Equipment & Services
Sub-Industry
Oil & Gas Equipment & Services
Current Symbol
NYSE:CLB
CIK
1958086
Fax
N/A
Employees
3,300
Year Founded
1936

Price Target and Rating

High Price Target
$21.00
Low Price Target
$21.00
Potential Upside/Downside
+168.7%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.38
Trailing P/E Ratio
20.52
Forward P/E Ratio
9.89
P/E Growth
1.7
Net Income
$29.67 million
Net Margins
3.42%
Pretax Margin
5.38%
Return on Equity
8.94%
Return on Assets
4.22%

Debt

Debt-to-Equity Ratio
0.40
Current Ratio
2.19
Quick Ratio
1.60

Sales & Book Value

Annual Sales
$526.52 million
Price / Sales
0.68
Cash Flow
$0.99 per share
Price / Cash Flow
7.91
Book Value
$6.20 per share
Price / Book
1.26

Miscellaneous

Outstanding Shares
45,820,000
Free Float
45,246,000
Market Cap
$358.08 million
Optionable
Optionable
Beta
1.18

Social Links

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

This page (NYSE:CLB) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners